Source: International Congress 2019 – Bronchiectasis
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Sabogal Piñeros (Amsterdam , Netherlands), J. Altenburg (Amsterdam , Netherlands), S. Vijverberg (Amsterdam , Netherlands), E. Hoefsmit (Amsterdam , Netherlands), B. Dierdorp (Amsterdam , Netherlands), T. Dekker (Amsterdam , Netherlands), W. Boersma (Amsterdam , Netherlands), R. Lutter (Amsterdam , Netherlands). Explorative analyses of inflammatory pathways and the effect of azithromycin in bronchiectasis patients. 2671

Member's Comments

No comment yet.

Related content which might interest you: The effect of maintenance azithromycin on radiological features in patients with bronchiectasis Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Analysis of effect of pentoxyphyllin in fibrosis development in tuberculous patients Source: Annual Congress 2010 - Scientific advances in tuberculosis Year: 2010 The effect of azithromycin on sputum inflammatory markers in bronchiectasis – analysis of a randomized controlled trial Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019 Effect of azithromycin treatment on inflammation in COPD patients Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Inhaled antibiotics improve symptoms of cough and sputum in patients with bronchiectasis: a post-hoc analysis of the AIR-BX studies Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 The effect of prednisone treatment on lung function test parameters in patients with chronic sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 433s Year: 2002 Evaluation of treatment with Nintedanib in patients with idiopathic pulmonary fibrosis: a proteomical approach Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Aspirin inhalation treatment for COPD patients: Preliminary studies on PK and inflammatory biomarkers Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 Analysis of microbiological colonization in COPD patients with or without bronchiectasis Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Effects of long-term azithromycin treatment in patients with non-cystic fibrosis stable bronchiectasis Source: Annual Congress 2007 - Infectious lung and pleural diseases Year: 2007 Comparative analysis of the efficacy of glucocorticosteroids and antimetabolite drugs in treatment of patients with pulmonary sarcoidosis Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 The association between bronchiectasis and systemic inflammation Source: International Congress 2019 – Bronchiectasis Year: 2019 Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort Source: Eur Respir J, 50 (4) 1700853; 10.1183/13993003.00853-2017 Year: 2017 The magnitude of pirfenidone treatment effect in patients with idiopathic pulmonary fibrosis (IPF): A pooled analysis of outcomes in the CAPACITY (CAP) studies Source: Annual Congress 2010 - New insights in the treatment of idiopathic pulmonary fibrosis Year: 2010 Study of the inflammatory phenotype of asthmatic patients with bronchiectasis Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Microbiological and inflammatory characteristics of exacerbations in COPD patients with comorbid radiographic bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019 Role of colonization on inflammation in COPD patients with bronchiectasis Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Macrolide effects on the prevention of COPD exacerbations Source: Eur Respir J 2012; 40: 485-494 Year: 2012 Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study. Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Enzymatic activity and clinical parameters in non-cystic fibrosis bronchiectasis: A cohort analysis Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012